Related content

Association of COLIA1 Sp1 polymorphism with the effect of subcutaneously injected recombinant hGH in GH-deficient adults

By Meyer Silke   Haist Marlitt   Schaefer Stephan   Ivan Diana   Ittner Jochen R   Nawroth Peter P   Plööckinger Ursula   Stalla Güünter K   Tuschy Ulrich   Weber Matthias M   Weise Alexander   Pfüützner Andreas   Habbe Nils   Kann Peter H  

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 1017-1026

Future Medicine

Access to resources Recommend Favorite

COLIA1 Sp1 polymorphism: towards individualized therapy with injected recombinant hGH in GH-deficient adults?

By Koch Christian A  

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 987-988

Future Medicine

Access to resources Recommend Favorite

Long-term growth hormone (GH) therapy increases final height in GH-deficient and some non-GH-deficient children

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 10, 2004-10 ,pp. : 15-17

Adis International

Access to resources Recommend Favorite

Cardiac ischemia and impairment of vascular endothelium function in hearts from GH-deficient rats: Protection by hexarelin

By De Gennaro Colonna V.   Rossoni G.   Bernareggi M.   Muller E.E.   Berti F.  

European Journal of Pharmacology, Vol. 334, Iss. 2, 1997-09 ,pp. : 201-207

Elsevier

Access to resources Recommend Favorite

Growth hormone dose in growth hormone-deficient adults is not associated with IGF-1 gene polymorphisms

By Meyer Silke   Schaefer Stephan   Ivan Diana   Stolk Lisette   Arp Pascal   Uitterlinden Andréé G   Nawroth Peter P   Plööckinger Ursula   Stalla Güünter K   Tuschy Ulrich   Weber Matthias M   Weise Alexander   Pfüützner Andreas   Kann Peter H  

Pharmacogenomics, Vol. 10, Iss. 2, 2009-02 ,pp. : 293-302

Future Medicine

Access to resources Recommend Favorite